Current Concept in Alveolar Cleft Management
Current Concept in Alveolar Cleft Management
Current Concept in Alveolar Cleft Management
Harvesting of bone can be done from the several syndrome.21-22 Aetiology of orofacial clefts is
areas and ilium is the area of choice due to its multifactorial and relate with gene factors,
simple access and availability of huge amount of environmental factors, and teratogens.23-24 Genetic
bone.13-15 To surpass the donor site morbidity of the susceptibility is the major element of orofacial clefts.
autograft, assaying to get new alternatives by utili- Genetics account for 40–60% of orofacial cleft has
zing the synthetic bone materials, bone morpho- identified through Monozygotic twin studies.25 The
genic proteins (BNP) and allografts (demineralized most widely investigated variants are TGF and
freeze-dried bone allograft or mineralized freeze- MTHFR genes. Phenotypes significantly associated
dried bone allograft). with particular partial aneuploidies have identified
through the survey of chromosomal deletions and
This review will discuss the pathogenesis and
duplications and found 1q25, 3p21, 4p15, 4q32 and
etiology of cleft defects, technique of operation, and
10p15 regions significantly associated with orofacial
assessment of the progress of alveolar bone graft
clefts. However, the identification of candidate
and proposed future materials for the bone graft.
genes is made intricate by some factors like genetic
heterogeneity, departure from Mendelian
inheritance patterns, limited availability and the
Pathogenesis and Classification high cost of genomic tools, and the necessity for
very large datasets.21, 24, 26-32
In the developmental period, the nose, lips and
palate are divided into primary and secondary Orofacial clefts can be influenced by environmental
palates. During the gestation period, medial and factors. In early pregnancy, folate supplementation
lateral sides of the nasal pits grow to form medial has reduced the risk from 2533 up to 75%,34 although
and lateral nasal prominence respectively. not all studies have reported statistical
Maxillary prominence lies inferior and lateral to the significance.35 Deficiency of zinc causes orofacial
nasal pits, and grows medially to fuse with the clefts in animals36 and may increase risk in
medial nasal process and form the primary palate16 humans.37 Maternal diabetes may be associated
which will form the bony and soft tissue with non-cardiac defects including orofacial clefts.38
components anterior to the incisive foramen (nose, In case of maternal age, the chance of orofacial clefts
lips, prolabium and pre-maxillae).17 Maxillary is more in above 40 years old comparison with 20-29
prominence also exhibits two shelves-like out-ward years old.39 Maternal smoking enhances the risk of
growth (palatine shelves) which course in several orofacial clefts up to 30%40 and indirect smoke
directions and finally fuse to form secondary exposure does not seem to affect.41 It is contro-
palate16 which will be formed posterior portion of versial with maternal alcohol consumption, but
maxillae or hard palate and soft palate. This fusion binge drinking increases the possibility.42 Maternal
process starts from incisive foramen and continues exposures to effective teratogens like retinoic acid,
up to uvula positioned at midline and complete by phenytoin, and valproic acid43 have been noticed.
nine weeks of gestation.18 Other possible causative agents such as chemical or
radiation exposures, stress, maternal obesity or
When palatine shelves failed to fuse each other will infection and hormonal drugs.21, 44
lead to forming the cleft palate. On the basis of
anatomical disruption of the primary and secondary
palate, this abnormality can be categorized into
complete or incomplete; unilateral or bilateral. Management of Alveolar Cleft
Complete cleft palate indicates primary and
Management of orofacial clefts is perplexing in
secondary palate failed to unite which is usually
nature. An extreme multidisciplinary collaboration
related with unilateral or bilateral cleft lip.19
team with the maxillofacial surgeon, orthodontist,
Incomplete cleft palate indicates only primary
phoniatric specialist, otolaryngologist, speech
palate or secondary palate fail to unite which may
therapist, pediatrician and dentist is necessary for
be confined within the soft palate only or may
treating the patient from birth to maturity.44-46
continue through soft and hard palate up to incisive
Remarkable interaction is present between positive
foramen or may be limited within the primary
treatment outcome and the availability of
palate causing alveolar cleft.20
centralized care by the qualified devoted team.
Maximum patients are diagnosed only after birth,
although orofacial clefts can be detected from 17
Etiology weeks of intrauterine life by the help ultrasound
scanning techniques. Cleft status, patient’s age as
Orofacial clefts are etiologically differ in syndromic well as medical status are the factors to determine
and non-syndromic form. Non-syndromic form of the service and treatment option for orofacial clefts
orofacial clefts occurs in 70% of cases, while 30% patient. Surgery is the choice of treatment to repair
with orofacial clefts associate with additional the deformities usually started from few months of
congenital anomalies, known to be part of life and most of the cases also need additional
BSMMU J 2017; 10: 195-203 197
surgical interventions later in life. Improvement of tissue can be harvested from various sites like iliac
aesthetics as well as function like feeding, speech, crest or wing, tibia, mandibular symphysis, radius,
breathing and hearing problems, can be achieved by calvarial bone, proximal humerus, distal ulna and
surgical treatment. Patients also need orthodontic ribs.61-66
care, speech therapy as well as social and psycho-
The autologous bone of the iliac crest is known as
logical services. Treatment plan of orofacial clefts
the optimum source and called as the gold standard
contains a range of services and needs to follow the
for the alveolar cleft reconstruction. Easy access and
manner from birth may up to adulthood stages.47-52
availability of sufficient amount of both cancellous
The alveolar osteoplasty is the process of fill up the and cortical bones are the remarkable benefits of
cleft gap with alveolar bone grafts, is the choice of harvesting bone grafts from the iliac crest over other
treatment with the aim of remove the oronasal donor sites.62, 63, 67 ‘Trephine’ technique can be
fistula, establishes maxillary arch continuity, limits helped to harvest sufficient amount cancellous
growth disturbance and movement of permanent bone68 as well as will be minimized hospitalization
dentition into the graft bone, enhance nasal period and duration of surgery, severity of pain;
symmetry, orthodontic movement and insertion of and painkiller use.69
dental implants, speech improvement, oral hygiene
At the beginning, it was a high expectation to
maintenance and improves of periodontal health.1
achieve a good result by the reconstruction of clefts
On the basis of development of palate, alveolar with the symphysis of mandible bone because of
osteoplasty can be classified into- similar embryonic origin (intramembranous), but
the actual problem is that only small amount of
1. Primary alveolar osteoplasty is made after lip
bone can be harvested from this site which is not
repair but before repair of the palate and should
sufficient for large unilateral or bilateral clefts
be done less than 2 years of age.53-54 Only rib graft
repair.60, 70, 71 However, having the chance of teeth’s
and calvarial bone graft are usually used for
root and mental nerve damage and the merits are
primary alveolar osteoplasty.55
rapid revascularization, low rate of resorption, same
2. Secondary alveolar osteoplasty is made after operative field, less post-operative pain.72
repair of the palate. It can be categories into early
Unremarkable scar formation, absence of functional
secondary (2-5 years), early (6-8 years) or late (9-
deformity, expediential surgical field, and availa-
12 years) mixed dentition, and late secondary
bility of sufficient amount bone are positive
grafting (after 13 years age).56-57
findings for reducing the operative adverse effects73
Complete palatal cleft and exactly aligned (end to as well as having chance of wound infection, small
end) alveolar segment are prerequisites for the amount of cancellous bone and intracranial compli-
primary alveolar osteoplasty, because of available cations (like hematoma, seroma, dural tear, dural
space between the maxillary segments will be exposure and cerebrospinal fluid leakage),74 while
exerted tension on flap over the graft bone and choosing calvarial bone graft. Study revealed that
enhance the possibility post-operative wound survival rate of cranial bone grafts is same as iliac
dehiscence, disclosure of graft and subsequent bone grafts which are approximately 85.0% and 84%
collapse of graft.53 Secondary alveolar osteoplasty respectively.75-76
helps to form the stable united alveolar arch as well
Regarding tibial bone graft in children, the outcome
as provide mature bony for supporting the tooth
is not satisfactory due chance of trauma causing
eruption.58-59 Secondary alveolar osteoplasty is the
hamper in growth.60 It is simple to harvest with
most acceptable and popular for treating alveolar
minimal bleeding, less post-operative pain and
cleft and commonly chose for the patient with age
permits quick ambulation as well as minimal period
of 6-13 years, usually before the permanent canine
of hospitalization; but the amount of graft bone is
eruption.
very small with an adult patient.
Various sort of bone graft material includes
It is one of the most common methods for alveolar
autografts, allografts, xenografts as well as bone
osteoplasty. Improper fitting with cleft bone, failure
graft substitutes are available to use in alveolar cleft
of eruption of teeth, insufficient support to alar
repair. Cortical, cancellous and cortico-cancellous
base; and chance of pneumothorax and pain
are different types of autogenic bone grafts.
postoperatively are the common complaints with
Alveolar cleft is considered as marginal bony defect
rib grafts.
and autologous cancellous graft play an important
role in formation and healing of bone due to its
property related with osteoconduction and act as Operative Technique
source of bony cells; is better to use for correcting
the defect.60 Available bone volume and morbidity The surgical procedure is performed under general
related to harvesting from definitive sites are anesthesia and the cleft area is infiltrated with
concerning issues for selection of donor area.60 Graft vasoconstrictor infiltration (1% xylocaine with epi-
198 BSMMU J 2017; 10: 195-203
A B C
Figure 1: Incisions are made on the buccal and palatal aspects of the alveolar cleft (A); For creating two full-thickness mucoperiosteal flaps
called medial and lateral mucoperiosteal flaps (B); Deposition of graft bone collected from donar site on the cleft region which finally lies
beneath the tension free sutured flaps (C)
nephrine) on the buccal and palatal aspect of the Major risks include infection, hematomas formation,
alveolar cleft. Two full-thickness mucoperiosteal different types of abnormalities (like subluxation
flaps are created by making incision (Figure 1A) and destabilization) of related joint, long-term (6
along the cleft margins which extend laterally months) standing pain, lack of sensation, abdominal
through the gingival sulcus of teeth up to molar contents herniation, fracture of related bones, and
teeth for getting sufficient mobility of flaps and abnormalities (like heterotopic) in hard tissues
raise the medial and lateral mucoperiosteal flaps regeneration (0.7 to 25%)77-79 and minor risks such
(Figure 1B). Then flaps are lifted from surrounding as problems with wound and infection, lack of
structures as well as from the area of the cleft. The sensation for short while and mild pain (4 to 49%).77
nasal mucosal layer is performed by interrupted
suturing while bony areas are fully visualized. Then
the palatal flaps are turned back and closed it by
Assessment of Progress of Alveolar
interrupted suturing for making a soft-tissue
pocket. Now, this isolated pocket is filled with Bone Graft
grafted cancellous bone collected from ilium. The The success of the bone graft can be assessed by
cleft defect should be compressed by the grafted clinical and radiological assessment. Clinical
bone to increase the number of bone particles per evaluation of alveolar bone graft includes eruption
unit graft volume. During inserting graft materials, of cleft teeth, periodontal status,80 alveolar height81-
level of acceptance is related to making the proper 84 and alar base support.80 Radiologically, the
shape of the cleft area comparison with nearest outcome will be assessed on the basis of appearance
surrounding structures for maintaining similarity as of the bone85 by using the Bergland scale and
well as aesthetic. Finally, flaps are closed by Chelsae scale86 which will continue at least six
suturing and need to make sure that sutured flap months postoperatively.
remains in lack of tension (Figure 1C).
Moreover, radiographic assessment seems to be
effective and superior to clinical methods.83-84
Accuracy of conventional (periapical, occlusal, and
Risk associated with Surgery orthopantogram) radiographs are not sufficient to
Risks associated with the alveolar bone graft get exact details of the cleft area for alveolar cleft
include graft resorption and alveolous notching assessment, CT scan should be used to overcome
may be happening with using of excessive graft these draw-backs in evaluating the alveolar cleft.87
materials; and exposure of wound by excessive CT scan and specialized software are necessary to
tension or trauma during recovery after surgery. assess the defect, for determining the amount to be
Study revealed that no more than 5% of patients are required for grafting as well as evaluation for post-
associated with graft failure.75 operative bone formation.88-89
deficits, iatrogenic fractures, and issues with evidence remains in vague, largely owing to the
cosmesis90-94 and availability of sufficient amount of vast array of available product types, and needs
grafting bone which is a momentous issue while further well-conducted prospective clinical trials
deformity is large. which might offer new exciting alternatives in the
near future.
Calcium phosphate graft materials like -tricalcium
phosphate ( -TCP) and hydroxyapatite known as
synthetic bone materials95-98 which have excellent
biocompatibility99 with easily producible, less
References
chance to spread diseases from one to another as 1. Peter E, Larsen D. Reconstruction of alveolar cleft.
well as their same composition (structural and In: Peterson’s Principles of oral and maxillofacial
chemical) with that of bone (inorganic part) assist in surgery. Miloro M, Ghali GE, Larsen P, Waite P
formation of bone.100 Outstanding properties of (eds). PMPH-USA, 2004, p 840.
hydroxyapatite (biocompatibility and osteoconduc-
2. Derijcke A, Eerens A, Carels C. The incidence of
tivity) makes it to choice able material for bone graft
oral clefts: A review. Br J Oral Maxillofac Surg.
in the implant dentistry.95-96 1996; 34: 488-94.
BMP have osteoinductive property. BMP-2, BMP-4 3. Shapira Y, Lubit E, Kuftinec MM, Borell G. The
and BMP-7 (different types of rhBMP) in along with distribution of clefts of the primary and secondary
appropriate carrier assist in reformation of missing palates by sex, type, and location. Angle Orthod.
tissue while associated with irregular hard tissue 1999; 69: 523-28.
defects.101-103
4. Bell WH, Proffit WR, White RP. Residual alveolar
Techniques of allograft for materials preparation and palatal cleft. In: Surgical correction of
(specially Tutoplast® and freeze-drying) also dentofacial deformities. Bell WH, Proffit WR,
reduce transmission of infection. 1 0 4 - 1 0 5 White RP (eds). Philadelphia, WB Saunders, 1980,
Demineralized freeze-dried bone allograft and pp 1329-67.
mineralized freeze-dried bone allograft are two 5. Larsen WJ, Schoenwolf GC. Development of face.
different types of Freeze-dried bone. It allows In: Larsen’s human embryology. Schoenwolf GJ
slower desorption than demineralized freeze-dried (ed). 4th ed. Philadelphia, Elsevier Churchill
bone allograft due to its mineralization and shows Livingstone, 2009, p 563-71.
an osteoconductive scaffold while used in mesen-
chymal tissues. Demineralized freeze-dried bone 6. Wójcicka K, Wójcicki P. Epidemiology of lip,
alveolar process and palate clefts in the material
allograft may have a higher osteoinductivity due to
of hospital and clinic of plastic surgery in polanica
its demineralization process than mineralized freeze
zdrój. Pol J Surg. 2009; 81: 4-11.
-dried bone allograft.106-108 Demineralized freeze-
dried bone allograft quickly revascularizes, and 7. Wójcicka K, Kobus K. Epidemiology of lip, alveo-
plays an important role on the extracellular matrix lar process and palate cleft-comparison of own
(especially growth factors and proteins) for the studies with data from Rother centre. Pol J Surg.
effect of their biological function.109 While replacing 2009; 81: 58-67.
autologous grafting, these two bone substitutes can 8. Wójcicka K, Kobus K. Etiopathoge-nesis of lip,
be used for getting a better response. alveolar process and palate clefts. Pol J Surg. 2008;
80: 546-52.
9. Woolf CM, Woolf RM, Broadbent TR. Genetic and
Conclusion non-genetic variables related to cleft lip and
palate. Plast Reconstr Surg. 1963; 32: 65.
With the passes of time, the treatment protocols of
alveolar cleft are becoming modified to improve the 10. Cobourne MT. Cleft lip and palate: Epidemiology,
functional as well as the esthetic purpose for better aetiology and treatment. Basel, Karger, 2012, p 16.
service of patients. Secondary alveolar osteoplasty
11. Turvey TA, Vig K, Moriarty J, Hoke J. Delayed
is the treatment of choice accepted by the majority
bone grafting in the cleft maxilla and palate: A
for alveolar cleft management. Autologous bone retrospective multidisciplinary analysis. Am J
grafts are constantly remained as gold standard for Orthod. 1984; 86: 244-56.
the reconstruction of alveolar cleft despite having
the risk and benefit feedbacks. Different types of 12. Albrektsson T. Healing bone grafts. In vivo studies
clinical circumstances are available which influence of tissue reaction at auto graft of bone in the rabbit
the local or systemic bone regeneration, and as of tibia, Thesis, University of Gothenburg, Sweden,
late different types of approaches are applied to 1979.
enhance bone repair, related with the potentiality of 13. Bonye PJ, Sand NR. Secondary bone grafting of
healing as well as the necessities of the individual residual alveolar and palatal cleft. J Oral Surg.
case. When it comes to bone graft substitutes, the 1972; 30: 87-92.
200 BSMMU J 2017; 10: 195-203
14. Johansson B, Ohlsson A, Friede H, Ahlgren J. A and palate closure. Nat Genet. 1999; 22: 69-73.
follow-up study of cleft lip and palate patients
treated with orthodontics, secondary bone graf- 30. van den Boogaard MJ, Dorland M, Beemer FA,
ting and prosthetic rehabilitation. Scand J Plast van Amstel HK. MSX1 mutation is associated
Reconstr Surg. 1974; 8: 121-35. with orofacial clefting and tooth agenesis in
humans. Nat Genet. 2000; 24: 342-43.
15. Abyholm FE, Bergland O, Semb G. Secondary
bone grafting of alveolar cleft. A surgical/ortho- 31. Osoegawa K, Vessere GM, Utami KH, Mansilla
dontic treatment enabling to a non-prosthodontic MA, Johnson MK. Identification of novel candi-
rehabilation in cleft and palate patients. Scand J date genes associated with cleft lip and palate
Plast Reconstr Surg. 1981; 15: 127-40. using array comparative genomic hybridization. J
Med Genet. 2008; 45: 81-86.
16. Sadler TW. Langmann’s Medical embryology. 7th
ed. Philadelphia, Williams and Wilkins, 1995. 32. Shi M, Mostowska A, Jugessur A, Johnson MK,
Mansilla MA. Identification of microdeletions in
17. Witt PD, Marsh JL. Cleft palate deformities. In: candidate genes for cleft lip and/or palate. Birth
Pediatricplastic surgery. Bentz M (ed). New York, Defects Res A Clin Mol Teratol. 2009; 85: 42-51.
Appletion and Lange, 1998, pp 93-105.
33. Wilcox AJ, Lie RT, Solvoll K, Taylor J,
18. Marks MW, Marks C. Cleft lip and palate. In: McConnaughey DR, Abyholm F. Folic acid
Fundamentals of plastic surgery. Marks MW, supplements and risk of facial clefts: National
Marks C (eds). Philadelphia, W.B. Saunders, 1997, population based case control study. BMJ. 2007;
pp 156-73. 334: 464.
19. Sadove AM, van Aalst JA, Culp JA. Cleft palate 34. Kelly D, O’Dowd T, Reulbach U. Use of folic acid
repair: Art and issues. Clin Plast Sur. 2004; 31: 231. supplements and risk of cleft lip and palate in
infants: A population-based cohort study. Br J
20. Jennifer LM, John FC, Dominick PC, John JS, John Gen Pract. 2012; 62: 466-72.
PF. Tissue engineering solutions for cleft palates. J
Oral Maxillofac. 2007; 65: 2503-11. 35. Wehby GL, Murray JC. Folic acid and orofacial
clefts: A review of the evidence. Oral Dis. 2010; 16:
21. Dixon MJ, Marazita ML, Beaty TH, Murray JC. 11-19.
Cleft lip and palate: Synthesizing genetic and
environmental influences. Nat Rev Genet. 2011; 36. Warkany J, Petering HG. Congenital malforma-
12: 167-78. tions of the central nervous system in rates
produced by maternal zinc deficiency. Teratology
22. Jones MC. Etiology of facial clefts: Prospective 1972; 5: 319-34.
evaluation of 428 patients. Cleft Palate J. 1988; 25:
16-20. 37. Tamura T, Munger RG, Corcoran C, Bacayao JY,
Nepomuceno B, Solon F. Plasma zinc concentra-
23. Calzolari E, Pierini A, Astolfi G, Bianchi F, Neville tions and the risk of non-syndromic oral clefts in
AJ, Rivieri F. Associated anomalies in multi- their children: A case-control study in the
malformed infants with cleft lip and palate: An Philippines. Birth Defects Res A Clin Mol Teratol.
epidemiological study of nearly 6 million births in 2005; 73: 612-16.
23 EUROCAT registries. Am J Med Genet. 2007;
143: 528-37. 38. Correa A, Gilboa SM, Besser LM, Botto LD, Moore
CA, Hobbs CA. Diabetes mellitus and birth
24. Murray JC. Gene/environment causes of cleft lip defects. Am J Obstet Gynecol. 2008; 199: 1-9.
and/or palate. Clin Genet. 2002; 61: 248–56.
39. Herkrath AP, Herkrath FJ, Rebelo MA, Vettore
25. Grosen D, Bille C, Petersen I, Skytthe A, Hjelm- MV. Parental age as a risk factor for non-
borg JV, Pedersen JK. Risk of oral clefts in twins. syndromic oral clefts: A meta-analysis. J Dent.
Epidemiology 2011; 22: 313-19. 2012; 40: 3-14
26. Schutte BC, Murray JC. The many faces and 40. Shi M, Wehby GL, Murray JC. Review on genetic
factors of orofacial clefts. Hum Mol Genet. 1999; 8: variants and maternal smoking in the aetiology of
1853-59. oral clefts and other birth defects. Birth Defects
27. Marazita ML, Mooney MP. Current concepts in Res C Embryo Today. 2008; 84: 16-29.
the embryology and genetics of cleft lip and cleft 41. Honein MA, Rasmussen SA, Reefhuis J, Romitti
palate. Clin Plast Surg. 2004; 31: 125-40. PA, Lammer EJ, Sun L. Maternal smoking and
28. Antonarakis GS, Patel RN, Tompson B. Oral environmental tobacco smoke exposure and the
health-related quality of life in non-syndromic risk of orofacial clefts. Epidemiology 2007; 18: 226-
cleft lip and/or palate patients: A systematic 33.
review. Community Dent Health. 2013; 30: 189-95.
42. De Roo LA, Wilcox AJ, Drevon CA, Lie RT. First-
29. Miettinen PJ, Chin JR, Shum L, Slavkin HC, Shuler trimester maternal alcohol consumption and the
CF. Epidermal growth factor receptor function is risk of infant oral clefts in Norway: A population-
necessary for normal craniofacial development based case control study. Am J Epidemiol. 2008;
BSMMU J 2017; 10: 195-203 201
47. Knežević P, Uglešić V, Jokić D, Kovačić J. Vaznost 61. Patel JC, Watson K, Joseph E, Garcia J, Wollstein
timskog pristupa u lijecenju malformacija. R. Long-term complications of distal radius bone
Gynaecol Perinatol. 2005; 14: 129. grafts. J Hand Surg [Am]. 2003; 28: 784-88.
48. Shaw GM, Nelson V, Carmichael SL, Lammer EJ, 62. Lee M, Song HK, Yang KH. Clinical outcomes of
Finnell RH, Rosenquist TH. Maternal periconcep- autogenous cancellous bone grafts obtained
tional vitamins: Interactions with selected factors through the portal for tibial nailing. Injury 2012,
and congenital anomalies? Epidemiology 2002; 13: 43: 1118-23.
625-30. 63. Mauffrey C, Madsen M, Bowles RJ, Seligson D.
49. Krapels IP, van Rooij IA, Ocké MC, West CE, van Bone graft harvest site options in orthopaedic
der Horst CM, Steegers-Theunissen RP. Maternal trauma: A prospective in vivo quantification
nutritional status and the risk for orofacial cleft study. Injury 2012; 43: 323-26.
offspring in humans. J Nutr. 2004; 134: 3106-13. 64. Vittayakittipong P, Nurit W, Kirirat P. Proximal
50. Lee ST. New treatment and research strategies for tibial bone graft: The volume of cancellous bone,
the improvement of care of cleft lip and palate and strength of decancellated tibias by the medial
patients in the new millennium. Ann Acad Med approach. Int J Oral Maxillofac Surg. 2012; 41: 531-
Singapore. 1999; 28: 760-67. 36.
51. Oosterkamp BC, Dijkstra PU, Remmelink HJ, Van 65. Bayod J, Becerro-de-Bengoa-Vallejo R, Losa-
Oort RP, Goorhuis-Brouwer SM, Sandham A, de Iglesias ME, Doblare M. Mechanical stress redis-
Bont LG. Satisfaction with treatment outcome in tribution in the calcaneus after autologous bone
bilateral cleft lip and palate patients. Int J Oral harvesting. J Biomech. 2012; 45: 1219-26.
Maxillofac Surg. 2007; 36: 890-95. 66. Garg B, Goyal T, Kotwal PP, Sankineani SR,
Tripathy SK. Local distal radius bone graft versus
52. Sinko K, Jagsch R, Prechtl V, Watzinger F, Holl-
mann K. Evaluation of esthetic, functional, and iliac crest bone graft for scaphoid nonunion: A
quality-of-life outcome in adult cleft lip and palate comparative study. Musculoskelet Surg. 2012.
patients. Cleft Palate Craniofac J. 2005; 42: 355-61. 67. Mahato NK. Characterization of cortico-cance-
llous bone along the iliac crest: Focus on graft
53. Eppley BL. Alveolar cleft bone grafting (Part I):
Primary bone grafting. J Oral Maxillofac Surg. harvesting. Surg Radiol Anat. 2011; 33: 433-37.
1996; 54: 74-82. 68. Ilankovan V, Stronczek M, Telfer M. A prospec-
tive study of trephined bone grafts of the tibial
54. Rosenstein SW. Early bone grafting of alveolar
shaft and iliac crest. Br J Oral Maxillofac Surg.
cleft deformities. J Oral Maxillofac Surg. 2003; 61:
1998; 36: 434-39.
1078-81.
55. Erichhorn W, Blessmann M, Pohllenz P, Blake FA, 69. Sharma S, Schneider LF, Barr J, Aarabi S, Chib-
Gehrke G, Schmelzle R, Heiland M. Primary baro P, Grayson B. Comparison of minimally
osteoplasty using calvarian bone in patient with invasive versus conventional open harvesting
cleft lip, alveolus and palate. J Cranio Maxillofac techniques for iliac bone graft in secondary
Surg. 2009; 37: 429-33. alveolar cleft patients. Plast Reconstr Surg. 2011;
128: 485-91.
56. Kazemi A, Stearns JW, Fonseca RJ. Secondary
grafting in the alveolar cleft patient. Oral 70. Bȃhr W, Coulon JP. Limits of the mandibular
Maxillofac Surg Clin North Am. 2002; 14: 477-90. symphysis as a donor site for bone grafts in early
secondary cleft palate osteoplasty. Int J Oral
57. Rychlik D, Wójcicki P, Koźlik M. Osteoplasty of Maxillofac Surg. 1996; 25: 389-93.
the alveolar cleft defect. Adv Clin Exp Med. 2012;
21: 255-62. 71. Enemark H, Jensen J, Bosch C. Mandibular bone
202 BSMMU J 2017; 10: 195-203
graft material for reconstruction of alveolar cleft grafting and subsequent orthodontic treatment.
defects: Long-term results. Cleft Palate Craniofac Cleft Palate J. 1986; 23: 175-205.
J. 2001; 38: 155-63.
86. Trindade, IK, Mazzottini R, da Silva, Filho O,
72. Rahpeyma A, Khajehahmadi S. Chin bone graft Trindade IEK, Deboni M. Long-term radiographic
for maxillary alveolar cleft: Indications and limita- assessment of secondary alveolar bone grafting
tions. J Craniofac Surg. 2014; 25: 1650-52. outcomes in patients with alveolar clefts. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod.
73. Keese E, Schmelzle R. New findings concerning 2005; 100: 271-77.
early bone grafting procedures in patients with
cleft lip and palate. J Cranio Maxillofac Surg. 1995; 87. Nightingale C, Witherow H, Reid FD, Edler R.
23: 296-301. Comparative reproducibility of three methods of
radiographic assessment of alveolar bone grafting.
74. Strong EB, Moulthrop T. Calvarial bone graft Eur J Orthod. 2003; 25: 35–41.
harvest: A new technique. Otolaryngol Head
Neck Surg. 2000; 123: 547-52. 88. Honma K, Kobayashi T, Nakajima T, Hayasi T.
Computed tomographic evaluation of bone
75. Hudak KA, Hettinger P, Denny AD. Cranial bone formation after secondary bone grafting of
grafting for alveolar clefts: A 25 year review of alveolar clefts. J Oral Maxillofac Surg. 1999; 57:
outcomes. Plast Reconstr Surg. 2014; 133: 662e- 1209-13.
68e.
89. Tai CC, Sutherland IS, McFadden L. Prospective
76. Oberoi S, Chigurupati R, Gill P, et al. Volumetric analysis of secondary alveolar bone grafting using
assessment of secondary alveolar bone grafting computed tomography. J Oral Maxillofac Surg.
using cone beam computed tomography. Cleft 2000; 58: 1241–49.
Palate Craniofac J. 2009; 46: 503-11.
90. Stevens KJ, Banuls M. Sciatic nerve palsy caused
77. Dösoğlu M, Orakdöğen M, Tevrüz M, by haematoma from iliac bone graft donor site.
Göğüsgeren MA, Mutlu F. Enterocutaneous Eur Spine J. 1994; 3: 291-93.
fistula: A complication of posterior iliac bone graft
harvesting not previously described. Acta 91. Banwart JC, asher Ma, Hassanein rs. Iliac crest
Neurochir (Wien). 1998; 140: 1089-92. bone graft harvest donor site morbidity. A
statistical evaluation. Spine (Phila Pa 1976) 1995;
78. Fernando TL, Kim SS, Mohler DG. Complete 20: 1055-60.
pelvic ring failure after posterior iliac bone graft
harvesting. Spine 1999; 24: 2101-04. 92. Schulhofer SD, Oloff LM. Iliac crest donor site
morbidity in foot and ankle surgery. J Foot Ankle
79. Younger EM, Chapman MW. Morbidity at bone Surg. 1997; 36: 155-58.
graft donor sites. J Orthop Trauma. 1989; 3: 192-
95. 93. Cricchio G, Lundgren S. Donor site morbidity in
two different approaches to anterior iliac crest
80. Tan AE, Brogan WF, McComb HK, Henry PJ. bone harvesting. Clin Implant Dent Relat Res.
Secondary alveolar bone grafting: Five-years 2003; 5: 161-69.
periodontal and radiographic evaluation in 100
consecutive cases. Cleft Palate Craniofac J. 1996; 94. Chou LB, Mann ra, Coughlin MJ, McPeake Wt III,
33: 513-18. Mizel Ms. Stress fracture as a complication of
autogenous bone graft harvest from the distal
81. Enemark H, Sindet-Pedersen S, Bundgaard M. tibia. Foot Ankle Int. 2007; 28: 199-201.
Long-term results after secondary bone grafting of
alveolar clefts. J Oral Maxillofac Surg. 1987; 45: 95. Misch CE, Dietsh F. Bone-grafting materials in
913-19. implant dentistry. Implant Dent. 1993; 2: 158–67.
82. Kindelan JD, Nashed RR, Bromige MR. Radiogra- 96. Holmes RE, Bucholz RW, Mooney V. Porous
phic assessment of secondary autogenous alveolar hydroxyapatite as a bone graft substitute in
bone grafting in cleft lip and palate patients. Cleft diaphyseal defects: A histometric study. J Orthop
Palate Craniofac J. 1997; 34: 195-98. Res. 1987; 5: 114–21.
83. Witherow H, Cox S, Jones E, Carr R, Waterhouse 97. Barralet J, Akao M, Aoki H, Aoki H. Dissolution
N. A new scale to assess radiographic success of of dense carbonate apatite subcutaneously
secondary alveolar bone grafts. Cleft Palate implanted in Wistar rats. J Biomed Mater Res.
Craniofac J. 2002; 39: 255-60. 2000; 49: 176–82.
84. Kokkinos PP, Ledoux WR, Kinnebrew MC, Wein- 98. Jensen SS, Broggini N, Hjørting-Hansen E, Schenk
berg R. Iliac apophyseal cartilage augmentation of R, Buser D. Bone healing and graft resorption of
the deficient piriform rim and maxilla in alveolar autograft, anorganic bovine bone and beta-trical-
cleft grafting. Am J Orthod Dentofacial Orthop. cium phosphate: A histologic and histomor-
1997; 112: 145-53. phometric study in the mandibles of minipigs.
Clin Oral Implants Res. 2006; 17: 237-43.
85. Bergland O, Semb G, Abyholm FE. Elimination of
the residual alveolar cleft by secondary bone 99. Elliot JC. Structure and chemistry of the apatites
BSMMU J 2017; 10: 195-203 203
and other calcium orthophosphates, 1st ed. vation in a bone allograft. J Periodontol. 1992; 63:
Amsterdam, Elsevier, 1994. 979-83.
100. Knowles JC. Phosphate based glasses for biomedi- 105. Schoepf C. The Tutoplast® process: A review of
cal applications. J Mater Chem. 2003; 13: 2395-401. efficacy. Zimmer Dental. 2008; 17: 40-50.
101. Gautschi OP, Frey SP, Zellweger R. Bone morpho-
genetic proteins in clinical applications. ANZ J 106. Mellonig JT, Bowers GM, Bailey RC. Comparison
Surg. 2007; 77: 626–31. of bone graft materials. Part I. New bone
formation with autografts and allografts deter-
102. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, mined by strontium-85. J Periodontol. 1981; 52:
Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski 291-96.
JP. Characterization of the distinct orthotopic
bone-forming activity of 14 BMPs using recombi- 107. Mellonig JT, Bowers GM, Cotton WR. Comparison
nant adenovirus-mediated gene delivery. Gene of bone graft materials. Part II. New bone
Ther. 2004; 11: 1312–20. formation with autografts and allografts: A
histological evaluation. J Periodontol. 1981; 52: 297
103. Katanec D, Granic M, Majstorovic M, Trampus Z, -302.
Panduric DG. Use of recombinant human bone
morphogenetic protein (rhBMP2) in bilateral 108. Urist MR. Bone: Formation by autoinduction.
alveolar ridge augmentation: Case report. Coll Science 1965; 150: 893-99.
Antropol. 2014; 38: 325-30.
109. Parikh SN. Bone graft substitutes: Past, present,
104. Mellonig JT, Prewett AB, Moyer MP. HIV inacti- future. J Postgrad Med. 2002; 48: 142-48.